RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain
Williams, RE., Hartmann, KE., Sandler, RS., Miller, WC., Savitz, L., & Steege, JF. (2005). Recognition and treatment of irritable bowel syndrome among women with chronic pelvic pain. American Journal of Obstetrics and Gynecology, 192(3), 761-767.
Objective: We sought to describe irritable bowel syndrome (IBS) treatment among women with chronic pelvic pain. Study design: We performed a cross-sectional study of new chronic pelvic pain patients between 1993 and 2000 (n = 987). IBS was defined by Rome I criteria. IBS treatment was defined as lower gastrointestinal drugs or referral. Analyses were descriptive and multivariable. Results: IBS occurred in 35% of patients. In the highest quartile of pain, women with IBS were not more likely to have IBS treatment initiated. In the lowest three quarters of pain, women with IBS were 5.08 times more likely to have IBS treatment initiated. IBS was not diagnosed 40% of the time. IBS treatments were not recommended to 67% of patients with IBS. More than 35% of patients were prescribed narcotics. Conclusion: IBS is not consistently diagnosed and treated even in a pelvic pain clinic. Yet, treatment of IBS may reduce the overall abdominal pain of these patients. (C) 2005 Elsevier Inc. All rights reserved